NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease
The primary objective of this study was to evaluate whether NLRP3 inflammasome blockade using either a ketogenic diet or HB supplementation decreased colitis susceptibility in mice with CGD compared to WT mice. The secondary objectives of the study were to determine if either or both treatment interventions